Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Lipocine (LPCN) Return on Assets (2016 - 2025)

Lipocine (LPCN) has disclosed Return on Assets for 13 consecutive years, with 0.32% as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Return on Assets fell 13.0% year-over-year to 0.32%, compared with a TTM value of 0.32% through Sep 2025, down 13.0%, and an annual FY2024 reading of 0.0%, up 54.0% over the prior year.
  • Return on Assets was 0.32% for Q3 2025 at Lipocine, down from 0.23% in the prior quarter.
  • Across five years, Return on Assets topped out at 0.1% in Q3 2022 and bottomed at 0.68% in Q4 2023.
  • Average Return on Assets over 5 years is 0.27%, with a median of 0.31% recorded in 2023.
  • The sharpest move saw Return on Assets surged 82bps in 2021, then crashed -69bps in 2023.
  • Year by year, Return on Assets stood at 0.01% in 2021, then plummeted by -1946bps to 0.28% in 2022, then plummeted by -145bps to 0.68% in 2023, then skyrocketed by 100bps to 0.0% in 2024, then plummeted by -81848bps to 0.32% in 2025.
  • Business Quant data shows Return on Assets for LPCN at 0.32% in Q3 2025, 0.23% in Q2 2025, and 0.25% in Q1 2025.